It is likely that NGAL and KIM-1 will emerge as temporally sequential biomarkers of AKI, with NGAL being most sensitive at the earliest time points and KIM-1 adding significant specificity at slightly later time points. The gene discussed is HAVCR1; the disease is acute kidney injury.